Watermark Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$2K Hold
39
﹤0.01% 239
2018
Q3
$3K Hold
39
﹤0.01% 194
2018
Q2
$3K Hold
39
﹤0.01% 193
2018
Q1
$3K Hold
39
﹤0.01% 197
2017
Q4
$3K Hold
39
﹤0.01% 198
2017
Q3
$3K Hold
39
﹤0.01% 195
2017
Q2
$3K Hold
39
﹤0.01% 201
2017
Q1
$3K Buy
+39
New +$2.74K ﹤0.01% 198

Other funds holding GILD

Watermark Asset Management's GILD Position: Q4 2018 in Review

Watermark Asset Management held its Gilead Sciences (GILD) position steady in Q4 2018 at 39 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #239.

Watermark Asset Management first reported a position in GILD in Q1 2017 and has held it in 8 quarters since. The position peaked at $3K in Q3 2018. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Watermark Asset Management held 39 shares of Gilead Sciences worth $2K as of Q4 2018.
  • Watermark Asset Management left its Gilead Sciences share count unchanged in Q4 2018.
  • Gilead Sciences made up ﹤0.01% of Watermark Asset Management's portfolio in Q4 2018, its #239 holding.
  • Watermark Asset Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 8 quarters since.
  • Watermark Asset Management's Gilead Sciences position peaked at $3K in Q3 2018.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Watermark Asset Management's 13F filing for Q4 2018, filed 14 Jan 2019.